BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24112376)

  • 1. Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.
    Kool MM; Galac S; Spandauw CG; Kooistra HS; Mol JA
    J Vet Intern Med; 2013; 27(6):1486-92. PubMed ID: 24112376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the ACTH receptor, steroidogenic acute regulatory protein, and steroidogenic enzymes in canine cortisol-secreting adrenocortical tumors.
    Galac S; Kool MM; Naan EC; Daminet S; Mol JA; Kooistra HS
    Domest Anim Endocrinol; 2010 Nov; 39(4):259-67. PubMed ID: 20920783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
    Bimpaki EI; Nesterova M; Stratakis CA
    Eur J Endocrinol; 2009 Jul; 161(1):153-61. PubMed ID: 19429701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor--phosphatidylinositol 3 kinase signaling in canine cortisol-secreting adrenocortical tumors.
    Kool MM; Galac S; van der Helm N; Corradini S; Kooistra HS; Mol JA
    J Vet Intern Med; 2015 Jan; 29(1):214-24. PubMed ID: 25619516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
    Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
    Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
    Libé R; Mantovani G; Bondioni S; Lania AG; Pedroni C; Beck-Peccoz P; Spada A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):248-51. PubMed ID: 15926108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cAMP signaling in cortisol-producing adrenal adenoma.
    Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
    Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.
    Almeida MQ; Azevedo MF; Xekouki P; Bimpaki EI; Horvath A; Collins MT; Karaviti LP; Jeha GS; Bhattacharyya N; Cheadle C; Watkins T; Bourdeau I; Nesterova M; Stratakis CA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E687-93. PubMed ID: 22259056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of receptors for luteinizing hormone, gastric-inhibitory polypeptide, and vasopressin in normal adrenal glands and cortisol-secreting adrenocortical tumors in dogs.
    Galac S; Kars VJ; Klarenbeek S; Teerds KJ; Mol JA; Kooistra HS
    Domest Anim Endocrinol; 2010 Jul; 39(1):63-75. PubMed ID: 20399066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of somatostatin, dopamine, progesterone and growth hormone receptor mRNA in canine cortisol-secreting adrenocortical tumours.
    Kool MM; Galac S; van der Helm N; Spandauw CG; Kooistra HS; Mol JA
    Vet J; 2015 Oct; 206(1):108-10. PubMed ID: 26143682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.
    Calebiro D; Hannawacker A; Lyga S; Bathon K; Zabel U; Ronchi C; Beuschlein F; Reincke M; Lorenz K; Allolio B; Kisker C; Fassnacht M; Lohse MJ
    Nat Commun; 2014 Dec; 5():5680. PubMed ID: 25477193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
    Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
    Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of autonomous cortisol secretion in a patient with subclinical Cushing's syndrome, GNAS mutation, and paradoxical cortisol response to dexamethasone.
    Sakaguchi C; Ashida K; Kohashi K; Ohe K; Fujii Y; Yano S; Matsuda Y; Sakamoto S; Sakamoto R; Oda Y; Nomura M; Ogawa Y
    BMC Endocr Disord; 2019 Jan; 19(1):13. PubMed ID: 30670014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: relationship with cell proliferation.
    Mantovani G; Lania AG; Bondioni S; Peverelli E; Pedroni C; Ferrero S; Pellegrini C; Vicentini L; Arnaldi G; Bosari S; Beck-Peccoz P; Spada A
    Exp Cell Res; 2008 Jan; 314(1):123-30. PubMed ID: 17904549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GNAS mutations in adrenal aldosterone-producing adenomas.
    Nakajima Y; Okamura T; Horiguchi K; Gohko T; Miyamoto T; Satoh T; Ozawa A; Ishii S; Yamada E; Hashimoto K; Okada S; Takata D; Horiguchi J; Yamada M
    Endocr J; 2016; 63(2):199-204. PubMed ID: 26743443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Mutational Analysis of Cortisol-Producing Adenomas.
    Rege J; Hoxie J; Liu CJ; Cash MN; Luther JM; Gellert L; Turcu AF; Else T; Giordano TJ; Udager AM; Rainey WE; Nanba K
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e594-e603. PubMed ID: 34534321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bursal anti-steroidogenic peptide (BASP) on cortisol biosynthesis in ACTH-stimulated canine adrenocortical carcinoma cells in vitro.
    Byrd JA; Dean CE; Fossum TW; Hargis BM
    Vet Immunol Immunopathol; 1995 Jul; 47(1-2):35-42. PubMed ID: 8533298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroidogenic factor-1 inverse agonists as a treatment option for canine hypercortisolism: in vitro study.
    Sanders K; Mol JA; Slob A; Kooistra HS; Galac S
    Domest Anim Endocrinol; 2018 Apr; 63():23-30. PubMed ID: 29223003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.